Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?

Ng CK, Shariat SF, Lucas SM, Bagrodia A, Lotan Y, Scherr DS, Raman JD.

Urol Oncol. 2011 Jan-Feb;29(1):27-32. doi: 10.1016/j.urolonc.2008.10.023. Epub 2008 Dec 30.

PMID:
19117771
2.

Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.

Ito Y, Kikuchi E, Tanaka N, Miyajima A, Mikami S, Jinzaki M, Oya M.

J Urol. 2011 May;185(5):1621-6. doi: 10.1016/j.juro.2010.12.035. Epub 2011 Mar 21.

PMID:
21419429
3.

Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F.

J Urol. 2009 Jun;181(6):2482-9. doi: 10.1016/j.juro.2009.02.021. Epub 2009 Apr 16.

PMID:
19371878
4.

Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.

Tanaka N, Kikuchi E, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakamura S, Oya M.

BJU Int. 2013 May;111(6):857-64. doi: 10.1111/j.1464-410X.2012.11353.x. Epub 2012 Jul 3.

5.

Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.

Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF.

J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.

PMID:
22698626
6.

Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?

Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M, Montorsi F, Bolenz C, Weizer AZ, Wheat JC, Ng CK, Scherr DS, Remzi M, Waldert M, Wood CG, Margulis V; Upper-Tract Urothelial Carcinoma Collaborative Group.

Urol Oncol. 2011 Nov-Dec;29(6):716-23. doi: 10.1016/j.urolonc.2009.11.007. Epub 2010 Jan 6.

PMID:
20056458
7.

Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort.

Bozzini G, Nison L, Colin P, Ouzzane A, Yates DR, Audenet F, Pignot G, Arvin-Berod A, Merigot O, Guy L, Irani J, Saint F, Gardic S, Gres P, Rozet F, Neuzillet Y, Ruffion A, Roupret M.

World J Urol. 2013 Feb;31(1):83-91. doi: 10.1007/s00345-012-0964-4. Epub 2012 Oct 11.

PMID:
23064982
8.

Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.

Hurel S, Rouprêt M, Ouzzane A, Rozet F, Xylinas E, Zerbib M, Berod AA, Ruffion A, Adam E, Cussenot O, Houlgatte A, Phé V, Nouhaud FX, Bensadoun H, Delage F, Guillotreau J, Guy L, Karsenty G, De La Taille A, Colin P; French Collaborative National Database on UTUC.

BJU Int. 2013 Jun;111(8):1199-207. doi: 10.1111/bju.12116. Epub 2013 Apr 12.

9.

Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.

Lughezzani G, Jeldres C, Isbarn H, Sun M, Shariat SF, Alasker A, Pharand D, Widmer H, Arjane P, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Eur J Cancer. 2009 Dec;45(18):3291-7. doi: 10.1016/j.ejca.2009.06.016. Epub 2009 Jul 15.

PMID:
19615885
10.

Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.

Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD.

Urol Oncol. 2013 Aug;31(6):904-8. doi: 10.1016/j.urolonc.2011.07.011. Epub 2011 Sep 9.

PMID:
21906967
11.

Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.

Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.

Urology. 2010 Feb;75(2):328-32. doi: 10.1016/j.urology.2009.07.1350.

PMID:
20018349
12.

[Pathological prognostic factors of renal pelvic and ureteral cancer].

Kumano M, Furukawa J, Yamanaka K, Tanaka K, Yamada Y, Hara I, Fujisawa M.

Nihon Hinyokika Gakkai Zasshi. 2006 Sep;97(6):786-90. Japanese.

13.

Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.

Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.

J Urol. 2007 May;177(5):1721-6.

PMID:
17437796
14.

Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Rieken M, Xylinas E, Kluth L, Trinh QD, Lee RK, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Kautzky-Willer A, Bachmann A, Shariat SF; UTUC Collaboration.

Eur J Surg Oncol. 2014 Jan;40(1):113-20. doi: 10.1016/j.ejso.2013.09.016. Epub 2013 Sep 20.

PMID:
24113620
15.
16.

Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma.

Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD.

J Urol. 2010 Jul;184(1):69-73. doi: 10.1016/j.juro.2010.03.030. Epub 2010 May 15.

PMID:
20478585
17.

Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.

Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

J Urol. 2009 Nov;182(5):2177-81. doi: 10.1016/j.juro.2009.07.035. Epub 2009 Sep 16.

PMID:
19758662
18.

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients.

Hall MC, Womack S, Sagalowsky AI, Carmody T, Erickstad MD, Roehrborn CG.

Urology. 1998 Oct;52(4):594-601.

PMID:
9763077
19.

Outcomes for patients with pT0 disease after radical nephroureterectomy for upper-tract urothelial carcinoma.

Raman JD, Ng CK, Shariat SF, Margulis V, Montorsi F, Karakiewicz P; Upper-Tract Urothelial Carcinoma Collaboration.

BJU Int. 2009 Jan;103(1):3-4. doi: 10.1111/j.1464-410X.2008.07938.x. Epub 2008 Aug 18. No abstract available.

20.
Items per page

Supplemental Content

Write to the Help Desk